| Particulars |
|
|
|
| Company Name
| Mankind Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
41.30 |
B.V. (₹) |
397.00 |
| Sales(₹ Cr.) |
10,421.18 |
NP (₹ Cr.) |
2,125.16 |
| NP Var% |
32.00 |
Div% |
100.00 |
| CPS(₹) |
61.80 |
EPS (₹) |
51.50 |
| Traded Value(₹ Lakhs) |
883.30 |
52 Week High |
2,640.00 |
| 52 Week Low |
1,910.00 |
Price BSE |
2,302.00 |
| Price NSE |
2,312.00 |
Market Capital (₹ Cr.) |
95,082.98 |
| P/C Ratio |
37.20 |
P/E Ratio |
44.70 |
| Price Vs.BV |
5.80 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
3,145.22 |
| NP(₹ Cr.) |
581.95 |
NP Var % |
27.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
9,288.12 |
| OPM |
27.44 |
NP |
2,004.35 |
| NP Var% |
34.70 |
EPS |
54.75 |
| PE |
42.05 |
|
|